Correlation Between Nuvation Bio and Evelo Biosciences
Can any of the company-specific risk be diversified away by investing in both Nuvation Bio and Evelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvation Bio and Evelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvation Bio and Evelo Biosciences, you can compare the effects of market volatilities on Nuvation Bio and Evelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvation Bio with a short position of Evelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvation Bio and Evelo Biosciences.
Diversification Opportunities for Nuvation Bio and Evelo Biosciences
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Nuvation and Evelo is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Nuvation Bio and Evelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evelo Biosciences and Nuvation Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvation Bio are associated (or correlated) with Evelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evelo Biosciences has no effect on the direction of Nuvation Bio i.e., Nuvation Bio and Evelo Biosciences go up and down completely randomly.
Pair Corralation between Nuvation Bio and Evelo Biosciences
If you would invest 298.00 in Nuvation Bio on August 31, 2024 and sell it today you would lose (8.00) from holding Nuvation Bio or give up 2.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Nuvation Bio vs. Evelo Biosciences
Performance |
Timeline |
Nuvation Bio |
Evelo Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nuvation Bio and Evelo Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvation Bio and Evelo Biosciences
The main advantage of trading using opposite Nuvation Bio and Evelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvation Bio position performs unexpectedly, Evelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will offset losses from the drop in Evelo Biosciences' long position.Nuvation Bio vs. Assembly Biosciences | Nuvation Bio vs. Instil Bio | Nuvation Bio vs. Achilles Therapeutics PLC | Nuvation Bio vs. NextCure |
Evelo Biosciences vs. Aileron Therapeutics | Evelo Biosciences vs. ABVC Biopharma | Evelo Biosciences vs. Surrozen | Evelo Biosciences vs. Processa Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies |